Victory Capital Management
CGEM icon

Victory Capital Management’s Cullinan Oncology CGEM Stock Holding History

Victory Capital Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-41,980
Closed -$443K – 2606
2022
Q4 		$443K Hold
41,980
– – ﹤0.01% 2046
2022
Q3 		$538K Buy
+41,980
New +$566K ﹤0.01% 2019
2022
Q2 		– Sell
-29,930
Closed -$313K – 2710
2022
Q1 		$313K Sell
29,930
-890
-3% -$12K ﹤0.01% 2280
2021
Q4 		$476K Sell
30,820
-1,430
-4% -$28.5K ﹤0.01% 2174
2021
Q3 		$728K Sell
32,250
-270
-0.8% -$7.22K ﹤0.01% 1992
2021
Q2 		$837K Sell
32,520
-2,150
-6% -$66.1K ﹤0.01% 1956
2021
Q1 		$1.45M Buy
+34,670
New +$1.41M ﹤0.01% 1743

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Victory Capital Management's CGEM Position: Q1 2023 in Review

Victory Capital Management sold out of Cullinan Oncology (CGEM) in Q1 2023, closing a stake of 41,980 shares — an estimated $443K sold.

Victory Capital Management first reported a position in CGEM in Q1 2021 and held it in 7 quarters. The position peaked at $1.45M in Q1 2021. 103 funds tracked by Wall St. Rank hold CGEM as of Q1 2023.

  • Victory Capital Management reported no remaining Cullinan Oncology position as of Q1 2023 after selling out during the quarter.
  • Victory Capital Management sold 41,980 Cullinan Oncology shares in Q1 2023, an estimated $443K.
  • Victory Capital Management first reported a position in Cullinan Oncology in Q1 2021 and held it in 7 quarters.
  • Victory Capital Management's Cullinan Oncology position peaked at $1.45M in Q1 2021.
  • 103 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2023.

Based on Victory Capital Management's 13F filing for Q1 2023, filed 2 May 2023.